Evidence map›Paper›PMID 32974725›Full record

ArticleJournal of general internal medicine2021

Comorbidity Management in Black Women Diagnosed with Breast Cancer: the Role of Primary Care in Shared Care.

Michelle Doose, Michael B Steinberg, Cathleen Y Xing, Yong Lin, Joel C Cantor, Chi-Chen Hong, Kitaw Demissie, Elisa V Bandera, Jennifer Tsui

Open access · bronzeAbstract read
In one paragraph

Article in Journal of general internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Importance of primary care for underserved cancer patients with multiple chronic conditions.Journal of cancer survivorship : research and practice · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Michelle DooseHealthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 9609 Medical Center Drive, 3E502, Rockville, MD, 20850, USA. michelle.doose@nih.gov.ORCID http://orcid.org/0000-0002-5300-8562
Michael B SteinbergRutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Cathleen Y XingRutgers School of Public Health, Piscataway, NJ, USA.
Yong LinRutgers School of Public Health, Piscataway, NJ, USA.
Joel C CantorRutgers Center for State Health Policy, New Brunswick, NJ, USA.
Chi-Chen HongUniversity at Buffalo, Buffalo, NY, USA.
Kitaw DemissieSUNY Downstate School of Public Health, Brooklyn, NY, USA.
Elisa V BanderaRutgers School of Public Health, Piscataway, NJ, USA.
Jennifer TsuiDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Rutgers, The State University of New Jersey · USRoswell Park Comprehensive Cancer Center · USSUNY Downstate Health Sciences University · USUniversity of Southern California · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Chang S Chan · 1997 to 2026
$94.5M
Reproduction, Lactation and Hormonal Factors in Breast Cancer SubtypesP01CA151135 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI AMBROSONE, CHRISTINE B., OLSHAN, ANDREW · 2011 to 2017
$18.1M
Obesity, related comorbidities, and breast cancer outcomes in African AmericansR01CA185623 · NCI · RBHS -CANCER INSTITUTE OF NEW JERSEY · PI BANDERA, ELISA V, DEMISSIE, KITAW · 2014 to 2018
$6.2M
Race &Risk Factors for Early/Aggressive Breast CancerR01CA100598 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI AMBROSONE, CHRISTINE B. · 2004 to 2008
$4.8M
DNA Methylation: a Mechanism for Aggressive Breast Cancer in African-American WomR01CA133264 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI AMBROSONE, CHRISTINE B., DEMISSIE, KITAW · 2010 to 2013
$3.6M
Obesity in ovarian cancer prognosisK22CA138563 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI BANDERA, ELISA V · 2010 to 2012
$605k
NCI NIH HHS K22 CA138563NCI NIH HHS P01 CA151135NCI NIH HHS P30 CA016056NCI NIH HHS P30 CA072720NCI NIH HHS R01 CA100598NCI NIH HHS R01 CA133264NCI NIH HHS R01 CA185623NCI NIH HHS R01CA185623, R01CA133264, R01 CA100598, P01 CA151135, K22 CA138563, P30CA072720, and P30 CA016056Susan G. Komen POP131006
6 · The paper itself

Abstract

backgroundBlack women are more likely to have comorbidity at breast cancer diagnosis compared with White women, which may account for half of the Black-White survivor disparity. Comprehensive disease management requires a coordinated team of healthcare professionals including primary care practitioners, but few studies have examined shared care in the management of comorbidities during cancer care, especially among racial/ethnic minorities.

objectiveTo examine whether the type of medical team composition is associated with optimal clinical care management of comorbidities.

designWe used the Women's Circle of Health Follow-up Study, a population-based cohort of Black women diagnosed with breast cancer. The likelihood of receiving optimal comorbidity management after breast cancer diagnosis was compared by type of medical team composition (shared care versus cancer specialists only) using binomial regression.

participantsBlack women with a co-diagnosis of diabetes and/or hypertension at breast cancer diagnosis between 2012 and 2016 (N = 274). MAIN MEASURES: Outcome-optimal clinical care management of diabetes (i.e., A1C test, LDL-C test, and medical attention for nephropathy) and hypertension (i.e., lipid screening and prescription for hypertension medication). Main predictor-shared care, whether the patient received care from both a cancer specialist and a primary care provider and/or a medical specialist within the 12 months following a breast cancer diagnosis. KEY

resultsPrimary care providers were the main providers involved in managing comorbidities and 90% of patients received shared care during breast cancer care. Only 54% had optimal comorbidity management. Patients with shared care were five times (aRR: 4.62; 95% CI: 1.66, 12.84) more likely to have optimal comorbidity management compared with patients who only saw cancer specialists.

conclusionsSuboptimal management of comorbidities during breast cancer care exists for Black women. However, our findings suggest that shared care is more beneficial at achieving optimal clinical care management for diabetes and hypertension than cancer specialists alone.

Indexed as

Black or African AmericanBreast NeoplasmsComorbidityFemaleFollow-Up StudiesHumansPrimary Health Carebreast cancercomorbiditypatient carepractice guidelineshared care

Identifiers

PMID32974725
PMCPMC7858725
OpenAlexW3088765544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.